Stock ScreenerStock IdeasZen Ratings + Top AnalystsStocks With a Zen Rating of A + Top Analyst consensus of Strong Buy + Large Upside in Target Price: Nov 8, 2025The 2 best sources of winning stocks is the Zen Ratings and our analysis of Top Analysts from Wall Street. Now we have combined them together in a best of both worlds approach to find stocks with the best upside potential.
Stock ScreenerStock IdeasZen Ratings + Top Analysts
Zen Rating: A
Upside/Downside: Large Upside
Top Analysts Consensus: Strong Buy
| Ticker | Company | Zen Rating | Price | Value | Graham Fair Value | Graham Fair Value % | P/E | Forward P/E | P/S | P/B | PEG | Free Cash Flow | Free Cash Flow Yield | Book Value | BVPS | EV | EV/EBITDA |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PTC | PTC INC | A | $173.93 | C | $68.96 | 152.21% | 40.83x | 23.43x | 8.44x | 5.93x | 1.44x | $849.78M | 4.07% | $3.51B | 29.30 | $22.05B | 24.90 |
| TPR | TAPESTRY INC | A | $98.81 | C | $43.55 | 126.91% | 72.65x | 17.85x | 2.85x | 50.62x | 1.02x | $1.08B | 5.27% | $399.50M | 1.92 | $23.70B | 39.62 |
| JAZZ | JAZZ PHARMACEUTICALS PLC | A | $134.05 | A | N/A | N/A | -22.38x | 24.94x | 1.96x | 2.06x | N/A | $1.34B | 16.43% | $3.96B | 65.23 | $12.23B | 66.98 |
| MOG.A | MOOG INC | A | $199.93 | C | $107.09 | 86.69% | 30.02x | 20.39x | 1.69x | 3.26x | 1.07x | $40.26M | 0.64% | $1.94B | 61.66 | $7.36B | 16.84 |
| SGHC | SUPER GROUP (SGHC) LTD | A | $11.75 | C | $7.23 | 62.52% | 23.59x | 24.93x | 2.37x | 6.86x | 0.99x | N/A | N/A | $866.28M | 1.71 | $5.49B | N/A |
| GTES | GATES INDUSTRIAL CORP PLC | A | $21.53 | B | $14.95 | 44.03% | 23.40x | 14.05x | 1.63x | 1.65x | 0.82x | $324.70M | 5.84% | $3.37B | 13.05 | $7.23B | 10.76 |
| CALX | CALIX INC | A | $64.37 | C | N/A | N/A | -643.70x | 47.87x | 4.53x | 5.19x | N/A | $85.45M | 2.02% | $822.51M | 12.51 | $4.18B | 409.45 |
| DLO | DLOCAL LTD | A | $13.60 | C | $7.79 | 74.57% | 26.67x | 21.15x | 4.63x | 8.92x | 1.03x | $116.61M | 2.92% | $447.96M | 1.53 | $3.58B | 14.68 |
| RSI | RUSH STREET INTERACTIVE INC | A | $16.55 | C | $4.65 | 256.20% | 50.15x | 41.00x | 1.50x | 28.53x | 2.22x | $91.18M | 5.73% | $133.08M | 1.38 | $3.52B | -106.50 |
| TPC | TUTOR PERINI CORP | A | $67.40 | B | N/A | N/A | -124.81x | 35.25x | 0.70x | 2.98x | N/A | $795.88M | 22.39% | $1.19B | 22.59 | $3.21B | 29.65 |
| MIRM | MIRUM PHARMACEUTICALS INC | A | $67.72 | C | N/A | N/A | -55.97x | -97.33x | 7.85x | 13.33x | N/A | $8.63M | 0.26% | $255.16M | 5.13 | $3.49B | -202.96 |
| FOLD | AMICUS THERAPEUTICS INC | A | $8.90 | C | N/A | N/A | -74.17x | -185.03x | 4.80x | 13.43x | N/A | -$48.91M | -1.79% | $204.30M | 0.66 | $3.03B | 91.58 |
| EXTR | EXTREME NETWORKS INC | A | $17.51 | C | $4.94 | 254.70% | 250.14x | 17.29x | 1.97x | 34.15x | 1.42x | $94.80M | 4.07% | $68.56M | 0.52 | $2.37B | 36.07 |
| SPNT | SIRIUSPOINT LTD | A | $19.37 | C | $20.78 | -6.80% | 11.67x | 8.52x | 0.79x | 1.02x | 0.63x | $236.50M | 10.46% | $2.21B | 18.93 | $2.23B | 6.57 |
| IHS | IHS HOLDING LTD | A | $6.41 | B | $5.08 | 26.07% | 18.85x | 17.61x | 1.24x | -7.94x | 0.75x | $787.93M | 36.63% | -$270.80M | -0.81 | $5.45B | N/A |
| ARDT | ARDENT HEALTH INC | A | $14.46 | A | $14.36 | 0.70% | 7.77x | 7.71x | 0.33x | 1.65x | 1.46x | $108.13M | 5.33% | $1.25B | 8.94 | $3.80B | 7.02 |
| FIVN | FIVE9 INC | A | $21.54 | A | $10.40 | 107.18% | 165.69x | 7.30x | 1.49x | 2.32x | 0.82x | $109.81M | 6.65% | $717.38M | 9.36 | $2.26B | 22.94 |
| BLBD | BLUE BIRD CORP | A | $50.54 | B | $37.93 | 33.24% | 13.92x | 11.58x | 1.12x | 7.22x | 1.09x | $143.11M | 8.97% | $221.85M | 7.03 | $1.52B | 8.65 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | A | $7.03 | B | N/A | N/A | -39.06x | 79.80x | 2.64x | -3.50x | N/A | $15.76M | 1.07% | -$421.59M | -2.01 | $2.13B | 33.51 |
| CRTO | CRITEO SA | A | $22.50 | A | $39.29 | -42.73% | 7.21x | 4.72x | 0.60x | 1.05x | 0.39x | $225.50M | 19.07% | $1.13B | 21.52 | $1.05B | 4.77 |
| NRDS | NERDWALLET INC | A | $11.98 | B | $6.40 | 87.10% | 30.72x | 24.80x | 1.21x | 2.40x | 1.06x | $55.30M | 6.22% | $371.60M | 5.01 | $800.46M | 15.63 |
| UDMY | UDEMY INC | A | $5.19 | B | N/A | N/A | -173.00x | 10.01x | 0.98x | 3.42x | N/A | $64.36M | 8.27% | $221.81M | 1.48 | $535.53M | 18.55 |
| TBPH | THERAVANCE BIOPHARMA INC | A | $14.87 | B | N/A | N/A | 59.48x | 15.79x | 9.66x | 3.33x | N/A | $244.78M | 32.80% | $224.85M | 4.48 | $512.57M | 10.59 |
| LYTS | LSI INDUSTRIES INC | A | $20.65 | B | $11.78 | 75.31% | 25.18x | 17.40x | 1.08x | 2.73x | 1.08x | $34.70M | 5.62% | $230.72M | 7.72 | $687.22M | 14.10 |
| BWMN | BOWMAN CONSULTING GROUP LTD | A | $34.46 | C | $18.21 | 89.27% | 215.38x | 46.54x | 1.27x | 2.43x | 0.73x | $29.49M | 5.23% | $244.12M | 14.93 | $740.40M | 30.77 |
| AKBA | AKEBIA THERAPEUTICS INC | A | $2.01 | C | N/A | N/A | -9.14x | -773.08x | 2.56x | 21.48x | N/A | -$34.69M | -7.31% | $24.58M | 0.10 | $463.16M | 42.60 |
| KMDA | KAMADA LTD | A | $6.62 | C | $3.75 | 76.41% | 20.06x | 16.97x | 2.25x | 1.46x | 1.32x | $31.60M | 8.29% | $259.95M | 4.52 | $326.11M | 9.53 |
| EGHT | 8X8 INC | A | $1.97 | A | N/A | N/A | -12.31x | 6.47x | 0.37x | 2.10x | N/A | $42.80M | 16.14% | $128.19M | 0.95 | $580.62M | 13.92 |
| NATR | NATURES SUNSHINE PRODUCTS INC | A | $13.73 | A | $9.76 | 40.73% | 17.83x | 14.47x | 0.55x | 1.48x | 0.95x | $22.36M | 8.85% | $163.68M | 8.89 | $176.42M | 4.07 |
| INFU | INFUSYSTEM HOLDINGS INC | A | $10.29 | C | $3.29 | 212.74% | 39.58x | 38.80x | 1.49x | 3.77x | 2.11x | $18.76M | 8.93% | $55.47M | 2.72 | $233.00M | 9.65 |
| CXDO | CREXENDO INC | A | $6.75 | C | $3.70 | 82.46% | 45.00x | 20.49x | 3.09x | 3.38x | 0.88x | $9.08M | 4.43% | $61.34M | 2.02 | $180.24M | 22.71 |
| ELMD | ELECTROMED INC | A | $24.34 | B | $8.78 | 177.25% | 27.35x | 24.10x | 3.22x | 4.70x | 2.45x | $11.13M | 5.41% | $43.21M | 5.11 | $187.93M | 16.60 |
Upgrade to Premium to View More
Use the proven Zen Ratings quant model to find stocks with high potential to beat the market. Stocks Zen-Rated "A" have beaten the market by +32.52% annually. Learn More
Already have access to Premium? Sign In
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.